Welcome to our dedicated page for Option Care Health SEC filings (Ticker: OPCH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Option Care Health, Inc. filings document the public-company disclosures of a Nasdaq-listed provider of home and alternate-site infusion services. Its common stock is registered under the symbol OPCH, and its regulatory record includes Current Reports on Form 8-K, proxy materials, and exhibits tied to operating results and corporate actions.
OPCH filings cover quarterly and annual financial results, non-GAAP measure reconciliations, Regulation FD investor presentations, amendments to its first lien credit agreement, executive officer changes and related severance matters, and definitive proxy disclosures. The proxy record addresses board governance, stockholder voting matters, executive compensation, and capital allocation context for the company's infusion services business.
Option Care Health, Inc. Chief Financial Officer Meenal Sethna bought 16,225 shares of common stock in an open-market purchase on May 4, 2026 at a weighted average price of $20.1587 per share.
The filing notes these shares were acquired through multiple trades at prices ranging from $19.94 to $20.38 per share. Following the transaction, Sethna directly owns 98,337 shares of Option Care Health common stock.
Option Care Health, Inc. Chief Executive Officer John Charles Rademacher reported an open-market purchase of 12,500 shares of common stock on May 4, 2026 at a weighted average price of $21.1765 per share. Following this transaction, he directly owns 695,152 common shares.
The shares were bought in multiple trades that day at prices ranging from $21.14 to $21.18 per share, indicating a modest incremental increase to his existing equity stake in the company.
Option Care Health reported steady Q1 2026 results, with net revenue of $1,350.7M, up slightly from $1,333.0M a year earlier. Net income was $45.3M versus $46.7M and diluted EPS rose to $0.29 from $0.28 as the share count declined.
Gross profit edged down to $262.0M and margin slipped to 19.4%, as strength in acute therapies was offset by pressure in chronic inflammatory disease treatments. Management now expects chronic inflammatory disease dynamics to reduce 2026 gross profit by about $55M.
The company ended the quarter with $177.3M in cash and expanded its revolving credit facility to $850.0M, leaving $846.0M available. It also repurchased 528,981 shares for $17.5M, with $675.0M remaining under its $1.0B authorization.
Vanguard Capital Management reports beneficial ownership of 8,228,614 shares (5.25%) of Option Care Health Inc common stock as of 03/31/2026. The filing states Vanguard has sole dispositive power over 8,228,614 shares and sole voting power for 1,212,291 shares. The disclosure notes these holdings include securities held for Vanguard funds and certain managed accounts and lists affiliated Vanguard entities that exercise voting or dispositive power.
Option Care Health reported mixed first quarter 2026 results, with net revenue of $1,350.7 million, up 1.3% year over year. GAAP net income was $45.3 million, down 3.0%, while GAAP diluted EPS rose to $0.29 and Adjusted diluted EPS held flat at $0.40.
Adjusted EBITDA was $104.8 million, down 6.3%, and operating activities used $12.1 million of cash. The company repurchased $17.5 million of stock and expanded its revolving credit facility from $400 million to $850 million, adding financial flexibility.
For full year 2026, Option Care Health now guides to net revenue of $5.675–$5.775 billion, Adjusted EBITDA of $480–$505 million, Adjusted diluted EPS of $1.82–$1.92, and at least $320 million of cash provided by operating activities, reflecting modest growth expectations.
Option Care Health Inc ownership disclosure: Vanguard Portfolio Management reported beneficial ownership of 8,201,422 shares of Common Stock, representing 5.24% of the class as of 03/31/2026. The filing notes these shares are held on behalf of Vanguard funds and managed accounts.
Option Care Health Chief Medical Officer Femi Adewunmi reported a tax-withholding disposition of 1,396 shares of Common Stock on April 22, 2026 at $28.38 per share. After this automatic withholding to cover tax obligations, Adewunmi directly holds 25,314 shares of Option Care Health Common Stock.
Option Care Health is asking stockholders at its 2026 virtual annual meeting to elect nine directors, ratify KPMG as independent auditor for 2026, and approve executive compensation on an advisory basis.
For 2025, the company reports net revenue of $5,649.5 million, up 13.0%, net income of $207.6 million, adjusted EBITDA of $471.3 million (up 6.2%), and adjusted EPS of $1.72 (up 8.9%). Cash provided by operating activities was $258.4 million. Management notes more than 2.5 million infusion events for over 315,000 patients, supported by about 8,000 team members.
The proxy emphasizes governance features such as one-share/one-vote, an independent board chair, annual director elections, proxy access, and stockholder-called special meetings at 25% ownership. Executive pay is heavily performance-based, with more than 85% of target CEO compensation tied to financial and stock performance, using annual incentives and PSU/RSU grants under robust ownership and clawback policies.
Option Care Health, Inc. entered into a Fifth Amendment to its Amended and Restated First Lien Credit Agreement with Bank of America, N.A. as administrative agent. The amendment adds new revolving credit commitments totaling $450,000,000, structured as an increase to the existing Revolving Credit Commitments.
Following this change, the aggregate principal amount of Revolving Credit Commitments available under the credit agreement is $850,000,000. This amendment updates the company’s senior secured lending facility and represents additional committed borrowing capacity rather than an immediate borrowing.